← Open Payments lookup

KASEY GROSS: Open Payments

NPI 1992944607 · ATTALLA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,709 in 92 payments from 10 companies in 2025. Trend: 2023 $1,219 · 2024 $1,512 · 2025 $1,709

Food & beverage: $1,709
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.21$476
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$353
E.R. Squibb & Sons, L.L.C.9$202
Alkermes, Inc.11$197
Lundbeck LLC6$117
Teva Pharmaceuticals USA, Inc.6$105
Janssen Pharmaceuticals, Inc4$91
Vanda Pharmaceuticals Inc.4$73
ABBVIE INC.3$59
Otsuka America Pharmaceutical, Inc.2$35

Products named: INGREZZA, CAPLYTA, COBENFY, ARISTADA, ABILIFY MAINTENA, FANAPT, INVEGA SUSTENNA, VRAYLAR.

Industry payments across AL — which companies pay providers there.